Michael Aaron Leabman Sells 3,377 Shares of Movano (NASDAQ:MOVE) Stock

Movano Inc. (NASDAQ:MOVE) CTO Michael Aaron Leabman sold 3,377 shares of the company’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $7.01, for a total transaction of $23,672.77. Following the transaction, the chief technology officer owned 31,560 shares of the company’s stock, valued at $221,235.60. This trade represents a 9.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Michael Aaron Leabman also recently made the following trade(s):

• On Wednesday, January 14th, Michael Aaron Leabman sold 6,845 shares of Movano stock. The shares were sold at an average price of $6.66, for a total value of $45,587.70.
• On Tuesday, January 13th, Michael Aaron Leabman sold 2,076 shares of Movano stock. The stock was sold at an average price of $6.94, for a total value of $14,407.44.
• On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The stock was sold at an average price of $7.27, for a total value of $5,692.41.
• On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The shares were sold at an average price of $7.26, for a total value of $26,085.18.
• On Wednesday, January 7th, Michael Aaron Leabman sold 3,293 shares of Movano stock. The stock was sold at an average price of $7.34, for a total value of $24,170.62.

Movano Price Performance

Movano stock opened at $7.03 on Friday. The business has a 50 day moving average of $8.92 and a 200-day moving average of $7.56. The company has a market capitalization of $5.83 million, a P/E ratio of -0.65 and a beta of 0.79. Movano Inc. has a 1 year low of $4.67 and a 1 year high of $58.76.

Movano (NASDAQ:MOVE) last posted its earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, topping the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The business had revenue of $0.08 million for the quarter, compared to the consensus estimate of $3.88 million.

Hedge Funds Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new position in shares of Movano Inc. (NASDAQ:MOVE) in the third quarter, according to its most recent filing with the SEC. The firm purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent quarter. Institutional investors and hedge funds own 16.64% of the company’s stock.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Institutional interest — Citadel Advisors disclosed a new position in MOVE (49,262 shares), signaling some institutional demand that can support the price in a thinly traded name. Read More.
• Positive Sentiment: Short interest eased in late December (decline vs. mid‑December), reducing one source of downward pressure and making the stock more responsive to small buying flows. Read More.
• Neutral Sentiment: Broader market context — geopolitical headlines and small‑cap weakness have driven volatility across the market this week; Movano’s moves may partly reflect sector / market flows rather than company‑specific news. Read More.
• Negative Sentiment: Clustered insider selling — CTO Michael Aaron Leabman sold multiple tranches this week (largest: 6,845 shares on Jan. 14 at ~$6.66), and other recent sales by him are disclosed in SEC filings. Concentrated insider sales in a microcap raise red flags for sentiment. Read More.
• Negative Sentiment: Additional insider exits — CFO Jeremy Cogan also disclosed notable sales in early January, further reducing insider stakes and adding to selling pressure. Read More.
• Negative Sentiment: Weak operating fundamentals — Movano’s latest quarterly results (Nov. 14) showed a large EPS loss despite beating consensus on the loss figure, with essentially negligible revenue (~$0.08M vs. analyst expectations materially higher). For a very small public company, that raises execution and dilution risk. Read More.
• Negative Sentiment: Microcap structural risk — tiny market cap, low average daily volume and an analyst consensus skewed to “Sell” amplify volatility and make it difficult for positive catalysts to sustain a rally absent operational progress. Read More.

Analysts Set New Price Targets

A number of research firms recently weighed in on MOVE. Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a report on Wednesday, October 8th. Wall Street Zen raised Movano to a “hold” rating in a research note on Saturday, December 20th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.